BIOMARIN PHARMACEUTICAL INC AOCI Including Portion Attributable to Noncontrolling Interest, before Tax
BIOMARIN PHARMACEUTICAL INC (BMRN) had AOCI Including Portion Attributable to Noncontrolling Interest, before Tax of $30.92 million as of 2015-09-30, per its 10-Q filed 2015-11-02.
Discontinued › Notes › Equity › Stockholders' Equity Note › AOCI Including Portion Attributable to Noncontrolling Interest
us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1 · last filed 2015-11-02
- 2015-09-30: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $30.92M.
- 2015-06-30: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $41.16M.
- 2015-03-31: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $54.50M.
- 2014-12-31: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax $33.98M.
| Period end | AOCI Including Portion Attributable to Noncontrolling Interest, before Tax | AOCI Including Portion Attributable to Noncontrolling Interest, before Tax as first filed |
|---|---|---|
| 2015-09-30 | $30.92M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $41.16M 10-Q · filed 2015-11-02 | |
| 2015-03-31 | $54.50M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $33.98M 10-Q · filed 2015-11-02 | |
| 2014-09-30 | $29.96M 10-Q · filed 2015-11-02 | |
| 2014-06-30 | $15.49M 10-Q · filed 2015-11-02 | |
| 2014-03-31 | $11.30M 10-Q · filed 2015-08-05 | |
| 2013-12-31 | $7.76M 10-Q · filed 2015-11-02 | $7.76M 10-Q · filed 2014-05-02 |
| 2013-09-30 | $16.98M 10-Q · filed 2014-10-28 | |
| 2013-06-30 | $3.80M 10-Q · filed 2014-10-28 | |
| 2013-03-31 | $1.82M 10-Q · filed 2014-07-31 | |
| 2012-12-31 | -$182.00K 10-K · filed 2015-03-02 | -$222.00K 10-Q · filed 2014-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |